rs886058900
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_000158.4(GBE1):c.1604A>G(p.Tyr535Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000502 in 1,595,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000158.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GBE1 | NM_000158.4 | c.1604A>G | p.Tyr535Cys | missense_variant | 12/16 | ENST00000429644.7 | |
GBE1 | XR_007095662.1 | n.1732A>G | non_coding_transcript_exon_variant | 12/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GBE1 | ENST00000429644.7 | c.1604A>G | p.Tyr535Cys | missense_variant | 12/16 | 1 | NM_000158.4 | P1 | |
GBE1 | ENST00000489715.1 | c.1481A>G | p.Tyr494Cys | missense_variant | 12/16 | 2 | |||
GBE1 | ENST00000484687.1 | n.5A>G | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000432 AC: 1AN: 231280Hom.: 0 AF XY: 0.00000795 AC XY: 1AN XY: 125816
GnomAD4 exome AF: 0.00000485 AC: 7AN: 1442918Hom.: 0 Cov.: 31 AF XY: 0.00000558 AC XY: 4AN XY: 716862
GnomAD4 genome ? AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74326
ClinVar
Submissions by phenotype
Glycogen storage disease, type IV Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 27, 2022 | The p.Tyr535Cys variant in GBE1 has been reported in 2 individuals, in the compound heterozygous state, with GBE1-related disorders (PMID: 20058079, 25728520), segregated with disease in 2 affected relatives from 1 family (PMID: 25728520), and has been identified in 0.002% (3/123296) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs886058900). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 346787) and has been interpreted as likely pathogenic by Illumina Clinical Services Laboratory (Illumina). In vitro functional studies provide some evidence that the p.Tyr535Cys variant may impact protein function (PMID: 25728520). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive GBE1-related disorder. ACMG/AMP Criteria applied: PP3, PP1, PM2, PS3_moderate (Richards 2015). - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 21, 2023 | - - |
GBE1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The GBE1 c.1604A>G (p.Tyr535Cys) missense variant has been reported in three studies in which it is found in a total of five individuals with either glycogen storage disease type IV or adult polyglucosan body disease, including in four in a compound heterozygous state and in one in a heterozygous state where a second variant was not identified (Massa et al. 2008; Li et al. 2010; Colombo et al. 2015). The variant has also been detected in at least one unaffected heterozygote. The p.Tyr535Cys variant was absent from at least 200 control chromosomes and is not found in the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. The Tyr535 residue is noted to be conserved. Functional studies in individual cells demonstrate that the variant results in enzyme activity in liver with some residual activity (30%) seen in cultured fibroblasts (Li et al. 2010). Based on the evidence the p.Tyr535Cys variant is classified as likely pathogenic for GBE1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Glycogen storage disease, type IV;C1856301:Glycogen storage disease IV, classic hepatic Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 04, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 535 of the GBE1 protein (p.Tyr535Cys). This variant is present in population databases (no rsID available, gnomAD 0.002%). This missense change has been observed in individual(s) with glycogen storage disease type IV (PMID: 20058079, 25728520). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 346787). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GBE1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at